Andrew Maiers, DO
Family Medicine · Fairmont, MNNPI 1417344938
Payments from drug & device makers
Across 12 payments — averaging $14.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$50
- Amgen$41
- Kerecis Limited$24
- Johnson & Johnson$17
- Bayer$15
- Pfizer$15
- plus $13 from 1 others
What the payments were for
- Food & beverage$176100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SPR Therapeutics, Inc | 4 | $50 |
| Amgen(2 entities) | 3 | $41 |
| Kerecis Limited | 1 | $24 |
| Johnson & Johnson | 1 | $17 |
| Bayer | 1 | $15 |
| Pfizer | 1 | $15 |
| Dexcom, Inc. | 1 | $13 |
How this compares
$176 in reported general payments places this provider in the 75th percentile of 1,162 family medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 34 | $21,392 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 12 | $7,630 |
| FarxigaDapagliflozin Propanediol | 11 | $5,726 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,787 |
| Fluticasone Propionate HfaFluticasone Propionate | 11 | $2,746 |
| Chlorzoxazone | 12 | $2,616 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 19 | $2,431 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 94 | $2,134 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $1,764 |
| Ventolin HfaAlbuterol Sulfate | 18 | $1,480 |
| Leflunomide | 50 | $1,213 |
| Ulticare Safety Pen NeedlePen Needle, Diabetic, Safety | 12 | $1,074 |
| Hydroxychloroquine Sulfate | 11 | $947 |
| Gabapentin | 67 | $848 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $836 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fairmont
- Jeffrey PetersonAda$3.6M
- Melissa ChoiSt Louis Park$825K
- John BensonMankato$498K
- Amanda LovoldSt Cloud$387K
- Robert MarshMinnetonka$300K
- Jolene BergEdina$250K
- Allan LuistroMoorhead$225K
- Mathew StaymanEast Grand Forks$220K
- Pamela NollMinneapolis$178K
- Taylor MertzMoorhead$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.